Broader Health Benefits Beyond Weight Loss

03 August 2025
Posted by Dr John Weight Loss Pharmacy
Observational studies suggest GLP-1 receptor agonists—including semaglutide and tirzepatide—might reduce risk of dementia (by 37%), stroke (19%), and overall mortality (30%) in overweight patients with diabetes.

More posts to explore